Safety, Tolerability and Pharmacokinetics of Single and Repeat Doses of GSK2292767 in Healthy Participants Who Smoke Cigarettes
Condition(s):AsthmaLast Updated:July 24, 2019Completed
Hide Studies Not Open or Pending
Condition(s):AsthmaLast Updated:July 24, 2019Completed
Condition(s):AsthmaLast Updated:October 28, 2020Completed
Condition(s):Diabetes Mellitus, Type 2Last Updated:October 16, 2017Completed
Condition(s):EpilepsyLast Updated:November 17, 2017Completed
Condition(s):Giant Cell ArteritisLast Updated:July 31, 2019Terminated
Condition(s):Hepatitis CLast Updated:December 6, 2013Completed
Condition(s):Graves Disease; Graves Ophthalmopathy; Liver Diseases; Liver Failure; Liver Injury; Liver Dysfunction; Liver Insufficiency; Acute Liver Failure; Acute Liver Injury; Acute Liver Injury, Drug Induced; Methylprednisolone Adverse Reaction; Glucocorticoids Toxicity; Dysthyroid Orbitopathy; Dysthyroid OphthalmopathyLast Updated:September 13, 2018Completed
Condition(s):Infection, Human Immunodeficiency VirusLast Updated:January 7, 2016Completed
Condition(s):AlopeciaLast Updated:October 11, 2018Completed
Condition(s):NeoplasmsLast Updated:March 25, 2024Active, not recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.